Report Detail
(Post-pandemic Era)-Global Oncology Precision Medicine Market Segment Research Report 2022
- RnM4476256 |
- 04 August, 2022 |
- Global |
- 128 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Oncology Precision Medicine Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Oncology Precision Medicine industry at home and abroad, estimate the overall market scale of the Oncology Precision Medicine industry and the market share of major countries, Oncology Precision Medicine industry, and study and judge the downstream market demand of Oncology Precision Medicine through systematic research, Analyze the competition pattern of Oncology Precision Medicine, so as to help solve the pain points of various stakeholders in Oncology Precision Medicine industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Oncology Precision Medicine Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Oncology Precision Medicine Market?
Abbott Laboratories
Agilent Technologies
Almac
ANGLE plc
Asuragen
BGI Group
Bio-Rad Laboratories
BioMérieux
Bristol Myers Squibb
Roche Holding AG
Gilead Sciences
Illumina
Konica Minolta
LabCorp
MDxHealth
Myriad Genetics
Novartis
OPKO Health
Pacific Biosciences
Quest Diagnostics
Qiagen
Major Type of Oncology Precision Medicine Covered in XYZResearch report:
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics
Application Segments Covered in XYZResearch Market
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Other Cancer
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Oncology Precision Medicine Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Oncology Precision Medicine Market by Value
- 2.2.1 Global Oncology Precision Medicine Revenue by Type
- 2.2.2 Global Oncology Precision Medicine Market by Value (%)
- 2.3 Global Oncology Precision Medicine Market by Production
- 2.3.1 Global Oncology Precision Medicine Production by Type
- 2.3.2 Global Oncology Precision Medicine Market by Production (%)
3. The Major Driver of Oncology Precision Medicine Industry
- 3.1 Historical & Forecast Global Oncology Precision Medicine Demand
- 3.2 Largest Application for Oncology Precision Medicine (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Oncology Precision Medicine Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Oncology Precision Medicine Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Oncology Precision Medicine Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Oncology Precision Medicine Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Oncology Precision Medicine Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Oncology Precision Medicine Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Oncology Precision Medicine Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Oncology Precision Medicine Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Oncology Precision Medicine Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Oncology Precision Medicine Average Price Trend
- 12.1 Market Price for Each Type of Oncology Precision Medicine in US (2018-2022)
- 12.2 Market Price for Each Type of Oncology Precision Medicine in Europe (2018-2022)
- 12.3 Market Price for Each Type of Oncology Precision Medicine in China (2018-2022)
- 12.4 Market Price for Each Type of Oncology Precision Medicine in Japan (2018-2022)
- 12.5 Market Price for Each Type of Oncology Precision Medicine in India (2018-2022)
- 12.6 Market Price for Each Type of Oncology Precision Medicine in Korea (2018-2022)
- 12.7 Market Price for Each Type of Oncology Precision Medicine in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Oncology Precision Medicine Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Oncology Precision Medicine
14. Oncology Precision Medicine Competitive Landscape
- 14.1 Abbott Laboratories
- 14.1.1 Abbott Laboratories Company Profiles
- 14.1.2 Abbott Laboratories Product Introduction
- 14.1.3 Abbott Laboratories Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 Agilent Technologies
- 14.2.1 Agilent Technologies Company Profiles
- 14.2.2 Agilent Technologies Product Introduction
- 14.2.3 Agilent Technologies Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 Almac
- 14.3.1 Almac Company Profiles
- 14.3.2 Almac Product Introduction
- 14.3.3 Almac Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 ANGLE plc
- 14.4.1 ANGLE plc Company Profiles
- 14.4.2 ANGLE plc Product Introduction
- 14.4.3 ANGLE plc Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 Asuragen
- 14.5.1 Asuragen Company Profiles
- 14.5.2 Asuragen Product Introduction
- 14.5.3 Asuragen Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 BGI Group
- 14.6.1 BGI Group Company Profiles
- 14.6.2 BGI Group Product Introduction
- 14.6.3 BGI Group Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 Bio-Rad Laboratories
- 14.7.1 Bio-Rad Laboratories Company Profiles
- 14.7.2 Bio-Rad Laboratories Product Introduction
- 14.7.3 Bio-Rad Laboratories Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 BioMérieux
- 14.8.1 BioMérieux Company Profiles
- 14.8.2 BioMérieux Product Introduction
- 14.8.3 BioMérieux Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 Bristol Myers Squibb
- 14.9.1 Bristol Myers Squibb Company Profiles
- 14.9.2 Bristol Myers Squibb Product Introduction
- 14.9.3 Bristol Myers Squibb Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
- 14.10 Roche Holding AG
- 14.10.1 Roche Holding AG Company Profiles
- 14.10.2 Roche Holding AG Product Introduction
- 14.10.3 Roche Holding AG Oncology Precision Medicine Sales, Revenue (2018-2022)
- 14.10.4 Strategic initiatives
- 14.11 Gilead Sciences
- 14.12 Illumina
- 14.13 Konica Minolta
- 14.14 LabCorp
- 14.15 MDxHealth
- 14.16 Myriad Genetics
- 14.17 Novartis
- 14.18 OPKO Health
- 14.19 Pacific Biosciences
- 14.20 Quest Diagnostics
- 14.21 Qiagen
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Oncology Precision Medicine. Industry analysis & Market Report on Oncology Precision Medicine is a syndicated market report, published as (Post-pandemic Era)-Global Oncology Precision Medicine Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Oncology Precision Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
